An Overview of Chronic Kidney Disease Pathophysiology: The Impact of Gut Dysbiosis and Oral Disease

被引:18
作者
Altamura, Serena [1 ,2 ,3 ]
Pietropaoli, Davide [1 ,3 ,4 ]
Lombardi, Francesca [5 ]
Del Pinto, Rita [1 ,3 ,6 ]
Ferri, Claudio [1 ,3 ,6 ]
机构
[1] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy
[2] Ctr Oral Dis Prevent & Translat Res Dent Clin, PhD Sch Med & Publ Hlth, I-67100 Laquila, Italy
[3] Oral Dis & Syst Interact Study Grp, ODISSY Grp, I-67100 Laquila, Italy
[4] Ctr Oral Dis Prevent & Translat Res Dent Clin, I-67100 Laquila, Italy
[5] Univ LAquila, Dept Life Hlth & Environm Sci, Lab Immunol & Immunopathol, I-67100 Laquila, Italy
[6] San Salvatore Hosp, Ctr Hypertens & Cardiovasc Prevent, Unit Internal Med & Nephrol, I-67100 Laquila, Italy
基金
美国国家卫生研究院;
关键词
chronic kidney disease; inflammation; uremic toxins; gut dysbiosis; oral disease; microbiota; probiotics; TRIMETHYLAMINE-N-OXIDE; STAGE RENAL-DISEASE; NONSURGICAL PERIODONTAL THERAPY; P-CRESYL SULFATE; BODY-MASS INDEX; OXIDATIVE STRESS; CARDIOVASCULAR RISK; METABOLIC-ACIDOSIS; INNATE IMMUNITY; UREMIC TOXINS;
D O I
10.3390/biomedicines11113033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chronic kidney disease (CKD) is a severe condition and a significant public health issue worldwide, carrying the burden of an increased risk of cardiovascular events and mortality. The traditional factors that promote the onset and progression of CKD are cardiometabolic risk factors like hypertension and diabetes, but non-traditional contributors are escalating. Moreover, gut dysbiosis, inflammation, and an impaired immune response are emerging as crucial mechanisms in the disease pathology. The gut microbiome and kidney disease exert a reciprocal influence commonly referred to as "the gut-kidney axis" through the induction of metabolic, immunological, and endocrine alterations. Periodontal diseases are strictly involved in the gut-kidney axis for their impact on the gut microbiota composition and for the metabolic and immunological alterations occurring in and reciprocally affecting both conditions. This review aims to provide an overview of the dynamic biological interconnections between oral health status, gut, and renal pathophysiology, spotlighting the dynamic oral-gut-kidney axis and raising whether periodontal diseases and gut microbiota can be disease modifiers in CKD. By doing so, we try to offer new insights into therapeutic strategies that may enhance the clinical trajectory of CKD patients, ultimately advancing our quest for improved patient outcomes and well-being.
引用
收藏
页数:29
相关论文
共 286 条
[1]   NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases [J].
Abderrazak, Amna ;
Syrovets, Tatiana ;
Couchie, Dominique ;
El Hadri, Khadija ;
Friguet, Bertrand ;
Simmet, Thomas ;
Rouis, Mustapha .
REDOX BIOLOGY, 2015, 4 :296-307
[2]   Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease [J].
Addi, Tawfik ;
Dou, Laetitia ;
Burtey, Stephane .
TOXINS, 2018, 10 (10)
[3]   Effect of Indoxyl Sulfate on the Repair and Intactness of Intestinal Epithelial Cells: Role of Reactive Oxygen Species' Release [J].
Adesso, Simona ;
Ruocco, Marco ;
Rapa, Shara Francesca ;
Dal Piaz, Fabrizio ;
Di Iorio, Biagio Raffaele ;
Popolo, Ada ;
Autore, Giuseppina ;
Nishijima, Fuyu ;
Pinto, Aldo ;
Marzocco, Stefania .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
[4]   Periodontal treatment in patients with chronic kidney disease: a pilot study [J].
Almeida, S. ;
Figueredo, C. M. ;
Lemos, C. ;
Bregman, R. ;
Fischer, R. G. .
JOURNAL OF PERIODONTAL RESEARCH, 2017, 52 (02) :262-267
[5]   Oral health as a modifiable risk factor for cardiovascular diseases [J].
Altamura, Serena ;
Del Pinto, Rita ;
Pietropaoli, Davide ;
Ferri, Claudio .
TRENDS IN CARDIOVASCULAR MEDICINE, 2024, 34 (04) :267-275
[6]   Inflammation and Progression of CKD: The CRIC Study [J].
Amdur, Richard L. ;
Feldman, Harold I. ;
Gupta, Jayanta ;
Yang, Wei ;
Kanetsky, Peter ;
Shlipak, Michael ;
Rahman, Mahboob ;
Lash, James P. ;
Townsend, Raymond R. ;
Ojo, Akinlolu ;
Roy-Chaudhury, Akshay ;
Go, Alan S. ;
Joffe, Marshall ;
He, Jiang ;
Balakrishnan, Vaidyanathapuram S. ;
Kimmel, Paul L. ;
Kusek, John W. ;
Raj, Dominic S. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (09) :1546-1556
[7]   The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease [J].
Anders, Hans-Joachim ;
Andersen, Kirstin ;
Stecher, Baerbel .
KIDNEY INTERNATIONAL, 2013, 83 (06) :1010-1016
[8]   Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation [J].
Andersen, Kirstin ;
Kesper, Marie Sophie ;
Marschner, Julian A. ;
Konrad, Lukas ;
Ryu, Mi ;
Kumar, Santhosh V. R. ;
Kulkarni, Onkar P. ;
Mulay, Shrikant R. ;
Romoli, Simone ;
Demleitner, Jana ;
Schiller, Patrick ;
Dietrich, Alexander ;
Mueller, Susanna ;
Gross, Oliver ;
Ruscheweyh, Hans-Joachim ;
Huson, Daniel H. ;
Stecher, Baerbel ;
Anders, Hans-Joachim .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (01) :76-83
[9]   Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients [J].
Ando, M. ;
Shibuya, A. ;
Tsuchiya, K. ;
Akiba, T. ;
Nitta, K. .
KIDNEY INTERNATIONAL, 2006, 70 (02) :358-362
[10]   Inflammation in Renal Diseases: New and Old Players [J].
Andrade-Oliveira, Vinicius ;
Foresto-Neto, Orestes ;
Mizuno Watanabe, Ingrid Kazue ;
Zatz, Roberto ;
Saraiva Camara, Niels Olsen .
FRONTIERS IN PHARMACOLOGY, 2019, 10